-
Je něco špatně v tomto záznamu ?
Lung cancer incidence in the Czech Republic: a time-trend study
V Janout, P Siroky, J Novak, L Cizek, H Koukalova, F Beska
Jazyk angličtina Země Švýcarsko
Typ dokumentu práce podpořená grantem
Grantová podpora
NO6585
MZ0
CEP - Centrální evidence projektů
- MeSH
- adenokarcinom epidemiologie patologie MeSH
- dospělí MeSH
- incidence MeSH
- lidé středního věku MeSH
- lidé MeSH
- nádory plic epidemiologie patologie MeSH
- průřezové studie MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- sexuální faktory MeSH
- spinocelulární karcinom epidemiologie patologie MeSH
- staging nádorů MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- práce podpořená grantem MeSH
- Geografické názvy
- Česká republika MeSH
BACKGROUND: Analysis of cancer incidence trends is one of the prerequisites for cancer prevention. It is possible to set up priorities and assess current development of morbidity. METHODS: All lung cancer incidences in the Moravia region of the Czech Republic (4,000,000 inhabitants) in the years 1984-1998 have been assessed concerning incidence, anatomical subsites, stage, and morphology. Age and sex distribution have been taken into consideration. RESULTS: There has been a continuous increase in the incidence of lung cancer in females and a mild decrease in males. In both sexes the most affected anatomical subsites were upper and lower lobe of the lung. Stage III and IV predominated. Main morphological type was squamous cell carcinoma in males (39.3%) and in females (22.2%), the second most frequent type in males was small cell carcinoma (13.6%) and in females adenocarcinoma (21.8%). The highest incidence was observed in the age group of 55-75 in males and 60-80 in females. CONCLUSION: Lung cancer epidemiology and prevention is one of the top-priority health problems in the Czech Republic. The incidence is one of the highest in the world especially for males; in females it is continuously increasing. Primary prevention is available but difficult to implement, particularly non-smoking. Secondary prevention is not available due to lack of suitable screening tests and a short lead time.
Department of Preventive Medicine Faculty of Medicine Palacky University Olomouc Czech Republic
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13003306
- 003
- CZ-PrNML
- 005
- 20190104104950.0
- 007
- ta
- 008
- 130123s2004 sz d f 000 0eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Janout, Vladimír, $d 1939- $7 jn20010524003 $u Department of Preventive Medicine, Faculty of Medicine, Palacky University, Olomouc, Czech Republic
- 245 10
- $a Lung cancer incidence in the Czech Republic: a time-trend study / $c V Janout, P Siroky, J Novak, L Cizek, H Koukalova, F Beska
- 500 __
- $a Literatura
- 520 9_
- $a BACKGROUND: Analysis of cancer incidence trends is one of the prerequisites for cancer prevention. It is possible to set up priorities and assess current development of morbidity. METHODS: All lung cancer incidences in the Moravia region of the Czech Republic (4,000,000 inhabitants) in the years 1984-1998 have been assessed concerning incidence, anatomical subsites, stage, and morphology. Age and sex distribution have been taken into consideration. RESULTS: There has been a continuous increase in the incidence of lung cancer in females and a mild decrease in males. In both sexes the most affected anatomical subsites were upper and lower lobe of the lung. Stage III and IV predominated. Main morphological type was squamous cell carcinoma in males (39.3%) and in females (22.2%), the second most frequent type in males was small cell carcinoma (13.6%) and in females adenocarcinoma (21.8%). The highest incidence was observed in the age group of 55-75 in males and 60-80 in females. CONCLUSION: Lung cancer epidemiology and prevention is one of the top-priority health problems in the Czech Republic. The incidence is one of the highest in the world especially for males; in females it is continuously increasing. Primary prevention is available but difficult to implement, particularly non-smoking. Secondary prevention is not available due to lack of suitable screening tests and a short lead time.
- 590 __
- $a bohemika - dle Pubmed
- 650 02
- $a adenokarcinom $x epidemiologie $x patologie $7 D000230
- 650 02
- $a dospělí $7 D000328
- 650 02
- $a senioři $7 D000368
- 650 02
- $a senioři nad 80 let $7 D000369
- 650 02
- $a spinocelulární karcinom $x epidemiologie $x patologie $7 D002294
- 650 02
- $a průřezové studie $7 D003430
- 650 02
- $a ženské pohlaví $7 D005260
- 650 02
- $a lidé $7 D006801
- 650 02
- $a incidence $7 D015994
- 650 02
- $a nádory plic $x epidemiologie $x patologie $7 D008175
- 650 02
- $a mužské pohlaví $7 D008297
- 650 02
- $a lidé středního věku $7 D008875
- 650 02
- $a staging nádorů $7 D009367
- 650 02
- $a sexuální faktory $7 D012737
- 651 _2
- $a Česká republika $x epidemiologie $7 D018153
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Široký, Pavel, $7 xx0130182 $u Masaryk Memorial Cancer Institute, Brno, Czech Republic $d 1957-
- 700 1_
- $a Novák, Jiří, $d 1959- $7 xx0071152 $u Masaryk Memorial Cancer Institute, Brno, Czech Republic
- 700 1_
- $a Čížek, Luděk, $d 1974- $7 xx0060784 $u Department of Preventive Medicine, Faculty of Medicine, Palacky University, Olomouc, Czech Republic
- 700 1_
- $a Koukalová, Hana $7 xx0130183 $u Department of Preventive Medicine, Faculty of Medicine, Palacky University, Olomouc, Czech Republic
- 700 1_
- $a Beška, František $7 xx0101298 $u National Cancer Registry, Ostrava, Czech Republic
- 773 0_
- $t Onkologie $x 0378-584X $g Roč. 27, č. 4 (2004), s. 376-379 $p Onkologie $w MED00003604
- 773 0_
- $p Onkologie $g 27(4):376-9, 2004 Aug $x 0378-584X
- 910 __
- $a ABA008 $y 3 $z 0
- 990 __
- $a 20130123152304 $b ABA008
- 991 __
- $a 20190104105146 $b ABA008
- 999 __
- $a ok $b bmc $g 965869 $s 801499
- BAS __
- $a 3
- BMC __
- $x MED00003604 $i 0378-584X $a 2004 $b 27 $c 4 $d 376-379 $m Onkologie (Basel) $n Onkologie
- GRA __
- $a NO6585 $p MZ0
- LZP __
- $a 2013-01/gvbo